About Our Company

Life Sciences Advanced Technologies continues to build on the well-established biochemical product line we have manufactured and distributed since 1962. For over fifty years, Life Sciences Advanced Technologies, Inc. has been the world’s leading commercial producer of native AMV Reverse Transcriptase. Life Sciences has evolved into Life Sciences Advanced Technologies, Inc. by building on its existing product lines.

Life Sciences Advanced Technologies is committed to providing quality enzymes and biochemical products with an emphasis on service, value and customer satisfaction.

We pride ourselves in striving to respond to your scientific needs with a sense of urgency and timeliness. Life Sciences has expanded our product line to meet the demands of the medical, scientific and research communities.

We are continuously collaborating with major pharmaceutical, biotechnology and research organizations to develop products that are impacting the global market. More specifically we have worked with companies, institutions, and individual research scientists to develop and improve products in PCR, isothermal amplification of nucleic acids, NASBA, enzyme modification, molecular biology and immunology.

Our corporate founders are among the best in the biotechnology industry, and our corporate executives have been selected for their expertise, experience and passion to innovate and share among peers and inspire other professionals to raise the bar in best practices.

Life Sciences Advanced Technologies, Inc. Corporate Officers and Executives

Our Corporate Board

Simon Srybnik
Chairman of the Board

Our Corporate Executives

Fred Perez
General Manager

Zhan Zhang, Ph.D.
Chief Technology Officer

Charles Kleim
Controller

Jason Perez
Business Development Director